Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF

Healthcare Biotechnology


GREY:IPHAF - Post by User

Isotechnika Pharma Inc > Paladin
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by wrongturnon Jul 08, 2010 2:59pm
408 Views
Post# 17254527

RE: RE: RE: Paladin

RE: RE: RE: PaladinUnfortunate that Foster isn't taking more steps to ensure the survival of ISA.  I think the writing is on the wall and it has been for quite some time that he needs to reduce monthly expenses while LUX spends a good part of 2011 trying to get their ducks in a row.

Mr Foster, if you are listening, their are still thousands of individuals alike me waiting for you to do the right thing.  I'm sure Paladin is trying to grease your wheels to screw over ISA shareholders.

ISA shareholder seeking safe harbour. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities